Search Within

Viktoriya Paroder

  1. "Journal of Clinical Oncology"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (1)
Groups
  1. Body Imaging Service (8)
  2. Department of Medicine (8)
  3. Radiology, Department of (8)
  4. Solid Tumor Oncology Division (8)
  5. Epidemiology and Biostatistics (7)
  6. Biostatistics Service (6)

More Groups

People
  1. Steven Maron (4)
  2. Yelena Janjigian (4)
  3. Alexia Iasonos (3)
  4. Geoffrey Ku (3)
  5. Jason Konner (3)
  6. Joanne Chou (3)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (3)
  4. 2020 (2)
  5. 2018 (1)
Publications
  1. Journal of Clinical Oncology (8)
Publishers
  1. American Society of Clinical Oncology (8)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Imaging HER2-positive metastatic esophagogastric cancer with (89)Zr-trastuzumab PET and (18)F-FDG PET
    Meeting Abstract

    Lumish, M. A.; Maron, S. B.; Paroder, V.; Philemond, S.; O'Donoghue, J. A.; Schoder, H.; Lewis, J. S.; Janjigian, Y. Y.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Secondary cytoreduction and carboplatin hyperthermic intraperitoneal chemotherapy for platinum-sensitive recurrent ovarian cancer: An MSK Team Ovary phase II study
    Journal Article

    Zivanovic, O.; Chi, D. S.; Zhou, Q.; Iasonos, A.; Konner, J. A.; Makker, V.; Grisham, R. N.; Brown, A. K.; Nerenstone, S.; Diaz, J. P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A randomized phase II trial of secondary cytoreductive surgery (SCS) plus /- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC)
    Meeting Abstract

    Zivanovic, O.; Chi, D.; Zhou, Q.; Iasonos, A.; Makker, V.; Grisham, R. N.; Konner, J. A.; Diaz, J. P.; Brown, A. K.; Langstraat, C. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Outcomes for matched patients with metastatic colitis-associated cancers versus sporadic colorectal cancer receiving chemotherapy
    Meeting Abstract

    Yaeger, R.; Hersch, J.; Bates, D.; Paroder, V.; Chou, J. F.; Tang, L. H.; Gollub, M. J.; Capanu, M.; Kelsen, D. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save